PATENT CLAIM ANALYSIS

Application Number: 16201142
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "093200"]

Abstract:
Compositions and methods are provided for modulating the activity of cells using engineered receptors, polynucleotide encoded engineered receptors, and gene therapy vectors comprising polynucleotides encoding engineered receptors. These compositions and methods find particular use in modulating the activity of neurons, for example in the treatment of disease or in the study of neuronal circuits.

Claim (Index 23):
The method according to  claim 22 , wherein the excitable cell is a neuron or a myocyte.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 98.0
- Lexical Diversity: 1.55263
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12576934', '10938370', '10703953', '10749075', '13367102']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7386375720040906
- 35 USC 102 Novelty (BERT): 0.5194829168244595
- Combined Prediction Score: 0.7167221064861276
- Mean Citation Score: 249.5609
- Max Citation Score: 274.61746
- Similarity Product: 173.95440893613338

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test